128 related articles for article (PubMed ID: 5779083)
1. [L-asparaginase, a new drug of antileukemic action].
Hernádi F
Orv Hetil; 1969 Jan; 110(4):187-9. PubMed ID: 5779083
[No Abstract] [Full Text] [Related]
2. [Clinical significance of L-asparaginase].
Benkö S
Orv Hetil; 1969 Aug; 110(35):2019-23. PubMed ID: 4900161
[No Abstract] [Full Text] [Related]
3. [Biochemical and genetic aspects of the use of L-asparaginase as an antileukemic factor].
Medvedev ZhA
Usp Sovrem Biol; 1971; 71(2):208-19. PubMed ID: 4935597
[No Abstract] [Full Text] [Related]
4. [Cytostatic effect of L-asparaginase].
Rakowska-Wódz A; Szyszka K; Abucewicz A
Wiad Lek; 1970 Jan; 23(2):117-20. PubMed ID: 4985374
[No Abstract] [Full Text] [Related]
5. [Asparaginase and acute leukemia].
Benbenishti D
Harefuah; 1971 Feb; 80(3):156. PubMed ID: 5099261
[No Abstract] [Full Text] [Related]
6. [Immunosuppressive effect of L-asparaginase].
Emmerling P; Finger H
Dtsch Med Wochenschr; 1970 Jul; 95(30):1578-9. PubMed ID: 5431973
[No Abstract] [Full Text] [Related]
7. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
Nervi C; Casale C; Cortese M
Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
[No Abstract] [Full Text] [Related]
8. Immunosuppressive action of L-asparaginase.
Alexander P
Proc R Soc Med; 1972 Mar; 65(3):265-6. PubMed ID: 5083314
[No Abstract] [Full Text] [Related]
9. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
Zhou J; Jin H; Li Y; Jiang T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of new antileukemic agents, with special reference to L-asparaginase, and cyclic maintenance therapy in acute leukemia].
Yamada K; Hirano M; Miura M
Nihon Ketsueki Gakkai Zasshi; 1969 Feb; 32(1):140-2. PubMed ID: 5388875
[No Abstract] [Full Text] [Related]
11. [Antileukemic action of L-asparaginase].
Yamada K; Hirano M; Kakizawa H; Morita A; Uetani T
Saishin Igaku; 1970 May; 25(5):1064-74. PubMed ID: 5421876
[No Abstract] [Full Text] [Related]
12. [Enzyme therapy of malignant tumors].
Jacobasch KH
Arch Geschwulstforsch; 1969; 34(4):364-75. PubMed ID: 4920119
[No Abstract] [Full Text] [Related]
13. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
Broome JD
Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
[No Abstract] [Full Text] [Related]
14. [Complete remission of lymphosarcoma cell leukemia with BACOP and L-asparaginase therapy--report of a case (author's transl)].
Tachibana A; Kimoto M; Yamaguchi H; Asai I; Tsukada T
Rinsho Ketsueki; 1977 Oct; 18(10):1260-5. PubMed ID: 592502
[No Abstract] [Full Text] [Related]
15. Clinical evaluation of L-asparaginase. Introduction.
Burchenal JH; Karnofsky DA
Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
[No Abstract] [Full Text] [Related]
16. [The treatment of acute leukemias with L-asparaginase].
Senn HJ
Praxis; 1969 May; 58(21):669-70. PubMed ID: 5819625
[No Abstract] [Full Text] [Related]
17. [The use of asparaginase preparations for the treatment of tumors and leukemia (review of the literature)].
Nikolaev AIa
Probl Gematol Pereliv Krovi; 1969 Jul; 14(7):51-60. PubMed ID: 4903458
[No Abstract] [Full Text] [Related]
18. [The role of L-asparaginase in the chemotherapy of tumors].
Cardinali G
Policlinico Prat; 1969 Mar; 76(9):276-80. PubMed ID: 4887557
[No Abstract] [Full Text] [Related]
19. [The antileukemic activity of asparaginase].
Guglielmi G; Iaschi P
Clin Ter; 1969 Dec; 51(5):481-4. PubMed ID: 5382106
[No Abstract] [Full Text] [Related]
20. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
Charles LM; Bono VH
Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
